Evidence map›Paper›PMID 42909767›Full record

ArticleIrish journal of medical science2026

Early selective deep capillary plexus impairment at diagnosis in children with type 1 diabetes: an OCT angiography study.

Şule Barman Kakil, Gül Trabzon

Abstract read
PubMed Publisher
In one paragraph

Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Şule Barman KakilDepartment of Ophthalmology, Tayfur Ata Sökmen Faculty of Medicine, Hatay Mustafa Kemal University, Hatay, Türkiye. sule.barmankakil@mku.edu.tr.ORCID http://orcid.org/0000-0002-5750-6825
Gül TrabzonDepartment of Pediatric Endocrinology, Tayfur Ata Sökmen Faculty of Medicine, Hatay Mustafa Kemal University, Hatay, Türkiye.ORCID http://orcid.org/0000-0002-9262-5678

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRetinal microvascular dysfunction may precede clinically visible diabetic retinopathy in children with type 1 diabetes mellitus (T1DM), but whether it is detectable at diagnosis remains unclear.

aimsTo evaluate retinal microvascular alterations at T1DM diagnosis using optical coherence tomography angiography (OCTA) and assess associations between deep capillary plexus (DCP) vessel density and metabolic severity.

methodsThis cross-sectional study included 50 children with newly diagnosed T1DM (100 eyes) and 50 age- and sex-matched controls (100 eyes). OCTA was performed using 6×6-mm macular and 4.5×4.5-mm optic disc scans. Vessel density (VD) was assessed in the superficial capillary plexus (SCP), DCP, and radial peripapillary capillary network. Foveal avascular zone metrics and retinal nerve fiber layer thickness were also analyzed. Linear mixed-effects models accounted for inter-eye correlation. Subgroup analyses were performed by HbA1c level and diabetic ketoacidosis (DKA) severity.

resultsSCP VD did not differ significantly between groups. DCP VD was lower in T1DM eyes in the whole image (53.1±3.0% vs 54.6±2.8%, p=0.006), parafoveal region (54.0±3.1% vs 55.8±2.9%, p=0.002), and perifoveal region (53.4±3.0% vs 54.7±2.8%, p=0.02). Peripapillary VD and retinal nerve fiber layer thickness were similar. Higher HbA1c was independently associated with lower DCP VD, which also declined with increasing DKA severity.

conclusionsDCP impairment is detectable at T1DM diagnosis before clinically visible diabetic retinopathy. OCTA may provide a sensitive, noninvasive biomarker of early retinal microvascular involvement in pediatric T1DM.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.